HomeAB3A • FRA
add
Sarepta Therapeutics Inc
Nakaraang pagsara
€35.23
Sakop ng araw
€34.19 - €34.19
Sakop ng taon
€31.26 - €160.05
Market cap
3.72B USD
Average na Volume
222.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 744.86M | 80.15% |
Gastos sa pagpapatakbo | 134.23M | 5.19% |
Net na kita | -447.51M | -1,338.98% |
Net profit margin | -60.08 | -787.41% |
Kita sa bawat share | -3.42 | -568.49% |
EBITDA | -290.41M | -765.33% |
Aktuwal na % ng binabayarang buwis | -16.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 522.76M | -62.41% |
Kabuuang asset | 3.47B | 7.47% |
Kabuuang sagutin | 2.32B | 2.63% |
Kabuuang equity | 1.14B | — |
Natitirang share | 98.28M | — |
Presyo para makapag-book | 3.03 | — |
Return on assets | -20.22% | — |
Return on capital | -27.97% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -447.51M | -1,338.98% |
Cash mula sa mga operasyon | -583.44M | -141.01% |
Cash mula sa pag-invest | -291.18M | -233.08% |
Cash mula sa financing | 12.47M | -43.67% |
Net change in cash | -862.14M | -75,526.58% |
Malayang cash flow | -501.94M | -143.47% |
Tungkol
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Itinatag
1980
Website
Mga Empleyado
1,372
